Aperio Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $110K | Buy |
19,184
+6,842
| +55% | +$39.2K | ﹤0.01% | 2375 |
|
|
2020
Q3 | $89K | Buy |
12,342
+2,235
| +22% | +$16.1K | ﹤0.01% | 2328 |
|
|
2020
Q2 | $35K | Sell |
10,107
-7,740
| -43% | -$26.8K | ﹤0.01% | 2311 |
|
|
2020
Q1 | $26K | Sell |
17,847
-18,941
| -51% | -$27.6K | ﹤0.01% | 2304 |
|
|
2019
Q4 | $73K | Buy |
36,788
+19,927
| +118% | +$39.5K | ﹤0.01% | 2286 |
|
|
2019
Q3 | $87K | Buy |
16,861
+2,325
| +16% | +$12K | ﹤0.01% | 2253 |
|
|
2019
Q2 | $104K | Buy |
+14,536
| New | +$104K | ﹤0.01% | 2378 |
|